Program
DC-806
A development code.
Its studies are mostly in Psoriasis, led by Eli Lilly.
Furthest: phase 2, since May 31, 20235 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Eli Lilly | 50 open or running | phase 2since May 31, 2023 | May 31, 2023 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 31, 2023First study: phase 2 study in Plaque PsoriasisFirst studyNCT05896527 · 229 enrolled · United States, Canada, Czechia and more
- Aug 9, 2023Phase 1 study in Healthy VolunteersNCT05994807 · 33 enrolled · United States
- Sep 13, 2023Phase 1 study in Healthy VolunteersNCT06045000 · 8 enrolled · Netherlands
- Oct 16, 2023Phase 1 study in Healthy ParticipantsNCT06092931 · 28 enrolled · United States
- Jan 31, 2025Phase 1 study in Plaque PsoriasisNCT06808815 · 104 enrolled · United Kingdom
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06808815Plaque Psoriasis · United Kingdom | 1 | Completed | Aug 23, 2022 | 104 |
| NCT06092931Healthy Participants · United States | 1 | Completed | Nov 28, 2023 | 28 |
| NCT06045000Healthy Volunteers · Netherlands | 1 | Completed | Oct 2, 2023 | 8 |
| NCT05994807Healthy Volunteers · United States | 1 | Completed | Sep 20, 2023 | 33 |
| NCT05896527Plaque Psoriasis · United States, Canada, Czechia and more | 2 | Completed | Mar 25, 2024 | 229 |
How it is read
Names in the registry
- “DC-806”, 5 entries
Codes read as this program: DC806.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.